NCT06914999
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +32 more
- Locations
-
- Emory University Hospital Midtown Atlanta, Georgia, United States
Clinical trial condition
Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Explore clinical trials studying Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8. Study availability and eligibility vary by location and protocol.
18 public trials
11 recruiting studies
Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 trial results
Not Yet Recruiting
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
NCT07441681
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +34 more
- Locations
-
Not specified
Not Yet Recruiting
Surgery Vs Chemoradiation for Oropharyngeal Cancer- A Phase II/III Integrated Design Randomized Control Trial
NCT05144100
- Conditions
- Carcinoma, Neoplasms, Neoplasms by Histologic Type, +3 more
- Locations
-
- Tata Memorial Hospital Mumbai, Maharashtra, India
NCT03258554
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +38 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- CTCA at Western Regional Medical Center Goodyear, Arizona, United States
Completed
Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer
NCT04870840
- Conditions
- Carcinoma, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, +35 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT04541355
- Conditions
- Carcinoma, Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +45 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
Active, Not Recruiting
Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin
NCT04533750
- Conditions
- Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous Cell Carcinoma, +34 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
Active, Not Recruiting
Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer
NCT04576091
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +52 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- Northwestern University Chicago, Illinois, United States
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States